NASDAQ : ORGO
Organogenesis Holdings Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 0.8189 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 105.37M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Organogenesis Holdings Inc. (ORGO) reported revenue of 457.45M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 454.61M | 563.03M | 482.04M | 433.14M | 450.89M | 467.36M |
| Other Revenue | 2.84M | 1.14M | ||||
| Revenue | 457.45M | 564.17M | 482.04M | 433.14M | 450.89M | 467.36M |
| Cost of Revenue | 130.43M | 132.34M | 115.74M | 106.48M | 105.02M | 114.20M |
| Gross Profit | 327.02M | 431.83M | 366.30M | 326.66M | 345.87M | 353.16M |
| Selling, General & Admin | 298.55M | 325.72M | 294.51M | 265.96M | 281.54M | 249.48M |
| Research & Development | 56.97M | 44.54M | 50.27M | 44.38M | 39.76M | 30.74M |
| Operating Expenses | 355.52M | 370.26M | 344.78M | 310.34M | 321.30M | 280.22M |
| Operating Income | -28.50M | 61.57M | 21.52M | 16.32M | 24.57M | 72.94M |
| Interest Expense | -1.54M | -2.19M | -2.01M | -7.24M | ||
| Interest & Investment Income | 1.17M | 2.28M | ||||
| Other Non Operating Income (Expenses) | -68.00K | -5.00K | 20.00K | 57.00K | -13.00K | -13.00K |
| EBT Excluding Unusual Items | -27.39M | 63.84M | 19.99M | 14.19M | 22.55M | 65.69M |
| Merger & Restructuring Charges | -516.00K | -516.00K | -3.80M | -2.27M | -4.70M | |
| Gain (Loss) on Sale of Assets | -1.67M | -11.18M | ||||
| Asset Writedown | -22.80M | |||||
| Other Unusual Items | -5.18M | -5.18M | 2.10M | |||
| Pretax Income | -34.77M | 46.97M | -2.81M | 10.39M | 20.28M | 63.09M |
| Income Tax Expense | 49.39M | 9.94M | -3.67M | 5.45M | 4.75M | -31.12M |
| Earnings From Continuing Operations | -84.16M | 37.03M | 861.00K | 4.95M | 15.53M | 94.20M |
| Net Income | -84.16M | 37.03M | 861.00K | 4.95M | 15.53M | 94.20M |
| Preferred Dividends & Other Adjustments | 17.53M | 17.01M | 1.80M | |||
| Net Income to Common | -101.68M | 20.02M | -937.00K | 4.95M | 15.53M | 94.20M |
| Shares Outstanding (Basic) | 127.57M | 126.74M | 131.67M | 131.23M | 130.07M | 128.33M |
| Shares Outstanding (Diluted) | 127.57M | 130.25M | 131.67M | 132.75M | 132.38M | 133.66M |
| EPS (Basic) | -0.80 | 0.16 | -0.01 | 0.04 | 0.12 | 0.73 |
| EPS (Diluted) | -0.80 | 0.15 | -0.01 | 0.04 | 0.12 | 0.70 |
| Free Cash Flow | 20.84M | -24.46M | 4.18M | 6.55M | -9.04M | 30.76M |
| Free Cash Flow Per Share | 0.16 | -0.19 | 0.03 | 0.05 | -0.07 | 0.23 |
| Gross Margin | 71.49% | 76.54% | 75.99% | 75.42% | 76.71% | 75.56% |
| Operating Margin | -6.23% | 10.91% | 4.46% | 3.77% | 5.45% | 15.61% |
| Profit Margin | -22.23% | 3.55% | -0.19% | 1.14% | 3.45% | 20.16% |
| Free Cash Flow Margin | 4.56% | -4.34% | 0.87% | 1.51% | -2.00% | 6.58% |
| EBITDA | -9.70M | 80.16M | 38.54M | 31.69M | 35.30M | 83.67M |
| EBITDA Margin | -2.12% | 14.21% | 8.00% | 7.32% | 7.83% | 17.90% |
| D&A For EBITDA | 18.80M | 18.60M | 17.03M | 15.37M | 10.73M | 10.73M |
| EBIT | -28.50M | 61.57M | 21.52M | 16.32M | 24.57M | 72.94M |
| EBIT Margin | -6.23% | 10.91% | 4.46% | 3.77% | 5.45% | 15.61% |
| Effective Tax Rate | 21.16% | 52.41% | 23.42% | |||
| Revenue as Reported | 457.45M | 564.17M | 482.04M | 433.14M | ||
| Advertising Expenses | 5.84M | 3.83M | 5.22M | 4.81M | 5.52M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 46.10M | 93.68M | 135.57M | 103.84M | 102.48M | 113.93M |
| Short-Term Investments | 2.24M | 309.00K | 872.00K | |||
| Cash & Short-Term Investments | 46.10M | 95.92M | 135.88M | 104.71M | 102.48M | 113.93M |
| Receivables | 100.94M | 217.45M | 109.86M | 82.00M | 89.45M | 82.46M |
| Inventory | 29.28M | 29.63M | 26.22M | 28.25M | 24.78M | 25.02M |
| Prepaid Expenses | 19.63M | 13.00M | 13.02M | 9.26M | 4.37M | 3.64M |
| Restricted Cash | 747.00K | 652.00K | 580.00K | 498.00K | 812.00K | 599.00K |
| Other Current Assets | 3.61M | 5.53M | 383.00K | 318.00K | 715.00K | 1.33M |
| Total Current Assets | 200.30M | 362.19M | 285.94M | 225.04M | 222.61M | 226.98M |
| Property, Plant & Equipment | 151.44M | 159.46M | 126.24M | 156.35M | 145.66M | 128.30M |
| Goodwill | 28.77M | 28.77M | 28.77M | 28.77M | 28.77M | 28.77M |
| Other Intangible Assets | 3.00M | 9.14M | 12.47M | 15.87M | 20.79M | 25.67M |
| Long-Term Deferred Tax Assets | 29.96M | 39.46M | 28.00M | 30.01M | 31.99M | |
| Long-Term Deferred Charges | 1.22M | |||||
| Other Long-Term Assets | 22.93M | 9.20M | 5.00M | 5.99M | 1.52M | 314.00K |
| Total Assets | 406.45M | 598.73M | 497.89M | 460.02M | 449.36M | 443.26M |
| Accounts Payable | 29.29M | 31.95M | 28.91M | 30.72M | 32.33M | 29.34M |
| Accrued Expenses | 18.36M | 44.41M | 31.22M | 21.36M | 20.43M | 30.32M |
| Current Portion of Long-Term Debt | 5.49M | 4.54M | 2.66M | |||
| Current Portion of Leases | 9.31M | 18.64M | 9.11M | 16.55M | 14.17M | 15.95M |
| Current Income Taxes Payable | 4.29M | 2.80M | 2.62M | 1.16M | ||
| Current Unearned Revenue | 3.86M | |||||
| Other Current Liabilities | 1.26M | 3.95M | 3.59M | 926.00K | 3.28M | |
| Total Current Liabilities | 56.96M | 100.12M | 77.48M | 80.51M | 75.02M | 82.70M |
| Long-Term Debt | 60.74M | 66.23M | 70.77M | |||
| Long-Term Leases | 57.64M | 63.49M | 34.20M | 38.90M | 41.31M | 46.89M |
| Other Long-Term Liabilities | 3.71M | 1.19M | 894.00K | 1.21M | 1.12M | 1.56M |
| Total Liabilities | 118.31M | 164.81M | 112.57M | 181.36M | 183.69M | 201.92M |
| Common Stock | 13.00K | 13.00K | 13.00K | 13.00K | 13.00K | 13.00K |
| Additional Paid-In Capital | 300.76M | 303.19M | 302.99M | 319.62M | 310.96M | 302.15M |
| Retained Earnings | -152.50M | -3.08M | -40.11M | -40.97M | -45.30M | -60.83M |
| Total Common Equity | 148.27M | 300.13M | 262.90M | 278.66M | 265.67M | 241.34M |
| Shareholders' Equity | 288.13M | 433.92M | 385.32M | 278.66M | 265.67M | 241.34M |
| Total Liabilities & Equity | 406.45M | 598.73M | 497.89M | 460.02M | 449.36M | 443.26M |
| Total Debt | 66.95M | 82.14M | 43.31M | 121.68M | 126.25M | 136.27M |
| Net Cash (Debt) | -20.85M | 13.79M | 92.57M | -16.96M | -23.78M | -22.34M |
| Net Cash Per Share | -0.16 | 0.11 | 0.70 | -0.13 | -0.18 | -0.17 |
| Filing Date Shares Outstanding | 128.67M | 128.64M | 126.83M | 131.96M | 131.18M | 128.77M |
| Total Common Shares Outstanding | 128.67M | 126.95M | 125.73M | 131.32M | 130.92M | 128.68M |
| Working Capital | 143.34M | 262.06M | 208.46M | 144.53M | 147.59M | 144.27M |
| Book Value Per Share | 1.15 | 2.36 | 2.09 | 2.12 | 2.03 | 1.88 |
| Tangible Book Value | 116.49M | 262.21M | 221.66M | 234.02M | 216.11M | 186.89M |
| Tangible Book Value Per Share | 0.91 | 2.07 | 1.76 | 1.78 | 1.65 | 1.45 |
| Buildings | 13.60M | 4.94M | 4.94M | 4.94M | ||
| Machinery | 69.23M | 63.25M | 64.58M | 57.15M | 53.96M | |
| Construction In Progress | 26.74M | 21.89M | 59.07M | 65.56M | 47.46M | |
| Leasehold Improvements | 67.87M | 63.34M | 60.82M | 37.61M | 30.53M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -84.16M | 37.03M | 861.00K | 4.95M | 15.53M | 94.20M |
| Depreciation & Amortization | 18.80M | 18.60M | 17.03M | 15.37M | 10.73M | 16.68M |
| Loss (Gain) From Sale of Assets | 2.21M | 11.36M | 1.14M | 235.00K | 4.48M | 1.41M |
| Asset Writedown & Restructuring Costs | 4.92M | 22.80M | ||||
| Stock-Based Compensation | 14.08M | 13.30M | 10.58M | 9.00M | 6.55M | 3.86M |
| Provision & Write-off of Bad Debts | 2.12M | 8.21M | 3.94M | 1.30M | 1.78M | 3.00M |
| Other Operating Activities | 68.93M | 33.57M | 6.75M | 18.15M | 19.87M | -20.16M |
| Change in Accounts Receivable | 17.32M | -115.80M | -31.80M | 5.54M | -8.77M | -28.65M |
| Change in Inventory | -13.84M | -17.91M | -6.20M | -8.18M | -9.41M | -9.30M |
| Change in Accounts Payable | -3.56M | -528.00K | -2.37M | -108.00K | 3.26M | 3.85M |
| Change in Other Net Operating Assets | 5.14M | 1.86M | -8.51M | -15.32M | -19.16M | -2.90M |
| Operating Cash Flow | 31.97M | -10.31M | 14.21M | 30.92M | 24.86M | 61.98M |
| Capital Expenditures | -11.13M | -14.15M | -10.03M | -24.36M | -33.90M | -31.22M |
| Investing Cash Flow | -11.13M | -14.15M | -10.03M | -24.36M | -33.90M | -31.22M |
| Long-Term Debt Issued | 73.17M | |||||
| Long-Term Debt Repaid | -1.17M | -67.64M | -5.17M | -3.01M | -75.19M | |
| Net Debt Issued (Repaid) | -10.79M | -1.17M | -67.64M | -5.17M | -3.01M | -2.01M |
| Issuance of Common Stock | 132.00K | 157.00K | 1.25M | 2.07M | 2.20M | |
| Repurchase of Common Stock | -3.14M | -1.89M | -26.65M | -332.00K | -648.00K | -737.00K |
| Other Financing Activities | -33.94M | -14.46M | -608.00K | -483.00K | ||
| Financing Cash Flow | -47.73M | -17.36M | 27.64M | -5.50M | -2.20M | -1.04M |
| Net Cash Flow | -26.89M | -41.82M | 31.81M | 1.05M | -11.24M | 29.72M |
| Free Cash Flow | 20.84M | -24.46M | 4.18M | 6.55M | -9.04M | 30.76M |
| Free Cash Flow Margin | 4.56% | -4.34% | 0.87% | 1.51% | -2.00% | 6.58% |
| Free Cash Flow Per Share | 0.16 | -0.19 | 0.03 | 0.05 | -0.07 | 0.23 |
| Levered Free Cash Flow | 28.45M | -46.86M | 10.22M | 10.79M | -17.38M | 23.45M |
| Unlevered Free Cash Flow | 28.45M | -46.86M | 11.18M | 12.16M | -16.13M | 27.97M |
| Cash Interest Paid | 4.97M | 5.44M | 2.65M | 5.79M | ||
| Cash Income Tax Paid | 5.35M | 5.35M | 6.96M | 3.05M | 1.20M | 607.00K |
| Change in Working Capital | 5.07M | -132.38M | -48.89M | -18.07M | -34.08M | -37.01M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 98.83M | 657.40M | 402.32M | 537.07M | 352.16M | 1.19B |
| Enterprise Value | 119.69M | 765.32M | 415.65M | 563.86M | 374.77M | 1.20B |
| Last Close Price | 0.77 | 5.18 | 3.20 | 4.09 | 2.69 | 9.24 |
| PE Ratio | 32.83 | 108.61 | 22.67 | 12.62 | ||
| Forward PE | 24.67 | 58.18 | 136.33 | 11.96 | 23.39 | |
| PS Ratio | 0.22 | 1.17 | 0.83 | 1.24 | 0.78 | 2.54 |
| PB Ratio | 0.67 | 1.51 | 1.04 | 1.93 | 1.33 | 4.92 |
| P/TBV Ratio | 0.85 | 2.51 | 1.81 | 2.29 | 1.63 | 6.36 |
| P/FCF Ratio | 4.74 | 96.34 | 81.96 | 38.65 | ||
| P/OCF Ratio | 3.09 | 28.32 | 17.37 | 14.17 | 19.18 | |
| PEG Ratio | 0.33 | 0.33 | 0.33 | 0.27 | 1.19 | |
| EV/Sales Ratio | 0.26 | 1.36 | 0.86 | 1.30 | 0.83 | 2.58 |
| EV/EBITDA Ratio | 9.55 | 10.78 | 17.80 | 10.62 | 14.40 | |
| EV/EBIT Ratio | 12.43 | 19.32 | 34.55 | 15.25 | 16.52 | |
| EV/FCF Ratio | 5.74 | 99.53 | 86.05 | 39.17 | ||
| Debt / Equity Ratio | 0.23 | 0.19 | 0.11 | 0.44 | 0.47 | 0.56 |
| Debt / EBITDA Ratio | 4.93 | 0.81 | 0.75 | 2.42 | 2.39 | 1.38 |
| Debt / FCF Ratio | 3.21 | 10.37 | 18.57 | 4.43 | ||
| Net Debt / Equity Ratio | 0.07 | -0.03 | -0.24 | 0.06 | 0.09 | 0.09 |
| Net Debt / EBITDA Ratio | -2.15 | -0.17 | -2.40 | 0.54 | 0.67 | 0.27 |
| Net Debt / FCF Ratio | 1.00 | 0.56 | -22.17 | 2.59 | -2.63 | 0.73 |
| Asset Turnover | 1.05 | 1.03 | 1.01 | 0.95 | 1.01 | 1.27 |
| Inventory Turnover | 4.19 | 4.74 | 4.25 | 4.01 | 4.22 | 4.32 |
| Quick Ratio | 2.58 | 3.13 | 3.17 | 2.32 | 2.56 | 2.38 |
| Current Ratio | 3.52 | 3.62 | 3.69 | 2.79 | 2.97 | 2.74 |
| Return on Equity (ROE) | -25.92% | 9.04% | 0.26% | 1.82% | 6.13% | 49.17% |
| Return on Assets (ROA) | -4.11% | 7.02% | 2.81% | 2.24% | 3.44% | 12.43% |
| Return on Invested Capital (ROIC) | -8.51% | 13.62% | 7.31% | 2.66% | 6.80% | 35.94% |
| Return on Capital Employed (ROCE) | -8.20% | 12.30% | 5.10% | 4.30% | 6.60% | 20.20% |
| Earnings Yield | -104.27% | 5.63% | 0.21% | 0.92% | 4.41% | 7.92% |
| FCF Yield | 21.09% | -3.72% | 1.04% | 1.22% | -2.57% | 2.59% |
| Buyback Yield / Dilution | 1.00% | 1.08% | 0.81% | -0.27% | 0.96% | -20.03% |